⌘K
Credent Connect SME IPO operates a comprehensive healthcare ecosystem and logistics platform. The company leverages established client relationships, an experienced management team, and a widespread domestic reach, supported by continuous investment in technological capabilities. It aims to deepen client engagement and expand its service offerings across various regions in India. Recent financial performance shows strong growth in revenue, EBITDA, and PAT, particularly in H1FY26, coupled with excellent return ratios.
The valuation appears attractive given the growth prospects. Market sentiment is overwhelmingly positive, evidenced by high subscription rates across all categories and strong anchor investor participation. While the business model is strong with competitive advantages, several high-level risks, including customer concentration, past negative cash flows, and ongoing litigations, warrant careful consideration.
The strong subscription across all categories, coupled with positive GMP trends during the IPO period, indicates a high probability of healthy listing gains. The attractive valuation and strong financials further support this outlook.
The company's robust financial performance in H1FY26, strong growth metrics, and positive market sentiment suggest good short-term prospects. However, investors should monitor the identified risks.
Credent Connect operates in a growing industry with a scalable business model and strong competitive advantages. While long-term growth potential is significant, the presence of customer concentration, cash flow, and litigation risks warrants careful monitoring for sustained performance.
| Category | Shares Offered | % of Issue | Share |
|---|---|---|---|
| QIB | 23,52,000 | 47.34% | |
| NII (HNI) | 7,08,000 | 14.25% | |
| Retail | 16,56,000 | 33.33% | |
| Market Maker | 2,52,000 | 5.07% |
| Investor | |||
|---|---|---|---|
| ABAKKUS VENTURE OPPORTUNITIES FUND | 2,64,600 | ₹5 Cr | 18.85% |
| MOTILAL OSWAL FINVEST LTD. | 2,11,800 | ₹4 Cr | 15.09% |
| 360 ONE LVF TREASURY SOLUTIONS FUND | 53,400 | ₹1.01 Cr | 3.8% |
| HEM GROWTH OPPORTUNITIES FUND | 2,37,000 | ₹4.48 Cr | 16.88% |
| MINT FOCUSED GROWTH FUND PCC-CELL 1 | 2,64,600 | ₹5 Cr | 18.85% |
| LRSD SECURITIES PVT.LTD. | 53,400 | ₹1.01 Cr | 3.8% |
| FINAVENUE CAPITAL TRUST-FINAVENUE GROWTH FUND | 53,400 | ₹1.01 Cr | 3.8% |
| MERU INVESTMENT FUND PCC-CELL 1 | 1,59,000 | ₹3.01 Cr | 11.32% |
| RELIGO COMMODITIES VENTURES TRUST-RELIGO COMMODITIES VENTURE FUND | 53,400 | ₹1.01 Cr | 3.8% |
| SHINE STAR BUILD-CAP PVT.LTD. | 53,400 | ₹1.01 Cr | 3.8% |
Premium gain of 29.1% over issue price.
Comprehensive Healthcare Ecosystem and Logistics Platform with widespread domestic reach.
Well-established relationships with clients and experienced Promoters and Directors.
Strong historical financial growth with Revenue CAGR of 14.64%, EBITDA CAGR of 41.79%, and PAT CAGR of 41.31%.
Exceptional return ratios: ROE of 61.81% and ROCE of 40.0% as of Mar 31, 2026.
Improving EBITDA and PAT margins, particularly strong in H1FY26.
Manageable debt levels with a Debt/Equity ratio of 0.5.
Overwhelmingly positive market sentiment with overall subscription of 153.13x and strong QIB/NII/Retail demand.
Presence of reputable anchor investors, signaling institutional confidence.
Attractive post-IPO P/E of 18.68x relative to growth prospects.
Continued strong demand in the healthcare logistics sector, successful expansion into new geographies, effective leveraging of technological investments, and sustained improvement in operational efficiencies leading to margin expansion.
Consistent execution of current growth strategies, stable client relationships, industry growth aligning with historical CAGR, and maintenance of H1FY26 profitability levels.
Increased competition, inability to renew key client contracts, persistent negative cash flow issues, adverse regulatory changes, or significant disruptions in supply chain for specialized materials.
Positive: Exceptional ROE (61.81%) and ROCE (40.0%) as of Mar 31, 2026.
Red flag: declining/negative profit trajectory (CAGR -15.4%)
Advisory: conflicting source data: roe_pct (investorgain_kpi=61.81 vs investorgain_highlights=14.2)
Listing-gain vs long-term: Apply / Apply.